Prostate cancer cell both microRNA aberrant expression-mediated autophagy and radiation therapy resistance with short cross-reference to epigenetic/genetic mechanism implications
Alberti, C.
European Review for Medical and Pharmacological Sciences 20(6): 1001-1002
2016
ISSN/ISBN: 1128-3602 PMID: 27049248 Document Number: 689678
Document emailed within 1 workday
Related Documents
Baas, F.; Jongsma, A.P.; Broxterman, H.J.; Arceci, R.J.; Housman, D.; Scheffer, G.L.; Riethorst, A.; van Groenigen, M.; Nieuwint, A.W.; Joenje, H. 1990: Non-P-glycoprotein mediated mechanism for multidrug resistance precedes P-glycoprotein expression during in vitro selection for doxorubicin resistance in a human lung cancer cell line Cancer Research 50(17): 5392-5398Jing, P.; Xu, W. 2015: Aberrant expression of microRNA in head and neck squamous cell carcinoma Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 50(10): 877-880
Yang, C.; Frenkel, K. 2002: Arsenic-mediated cellular signal transduction, transcription factor activation, and aberrant gene expression: implications in carcinogenesis Journal of Environmental Pathology Toxicology and Oncology: Official Organ of the International Society for Environmental Toxicology and Cancer 21(4): 331-342
Alberti, C. 2011: Organ-confined prostate carcinoma radiation brachytherapy compared with external either photon- or hadron-beam radiation therapy. just a short up-to-date European Review for Medical and Pharmacological Sciences 15(7): 769-774
Gnanasekar, M.; Thirugnanam, S.; Ramaswamy, K. 2009: Short hairpin RNA (shRNA) constructs targeting high mobility group box-1 (HMGB1) expression leads to inhibition of prostate cancer cell survival and apoptosis International Journal of Oncology 34(2): 425-431
Gao, Q-Neng. 2019: Stereotactic body radiation therapy versus conventional intensity-modulated radiation therapy for the treatment of prostate cancer Zhonghua Nan Ke Xue 25(5): 424-429
Wu, Y.; Zhang, Y.; Wan, L.; Chen, J.; Zhou, L.; Wang, X. 2013: Construction of microRNA-21 and PTEN eukaryotic expression and short hairpin RNA expression vectors Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 30(2): 359-364
Naramoto, H.; Uematsu, T.; Uchihashi, T.; Doto, R.; Matsuura, T.; Usui, Y.; Uematsu, S.; Li, X.; Takahashi, M.; Yamaoka, M.; Furusawa, K. 2007: Multidrug resistance-associated protein 7 expression is involved in cross-resistance to docetaxel in salivary gland adenocarcinoma cell lines International Journal of Oncology 30(2): 393-401
Zhang, S.; Cai, X.; Huang, F.; Zhong, W.; Yu, Z. 2008: Effect of trichostatin a on viability and microRNA expression in human pancreatic cancer cell line BxPC-3 Experimental Oncology 30(4): 265-268
Schäfer, U.; Micke, O.; Hampel, G.; Brandt, B.; Bovenschulte, A.; Semjonow, A.; Willich, N. 1997: The use of prostate-specific antigen (PSA) for the monitoring of radiation therapy in prostate cancer Anticancer Research 17(4b): 2983-2986
Nakagawa, M. 2014: MicroRNA in prostate cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 72(12): 2224-2228
Johnson, S.W.; Laub, P.B.; Beesley, J.S.; Ozols, R.F.; Hamilton, T.C. 1997: Increased platinum-DNA damage tolerance is associated with cisplatin resistance and cross-resistance to various chemotherapeutic agents in unrelated human ovarian cancer cell lines Cancer Research 57(5): 850-856
Gay, H.A.; Michalski, J.M. 2018: Radiation Therapy for Prostate Cancer Missouri Medicine 115(2): 146-150
Boccon-Gibod, L. 1996: Adjuvant radiation therapy for pT3 prostate cancer Acta Urologica Belgica 64(2): 65-66
Riccardi, V.M. 1979: Cell--cell interaction as an epigenetic determinant in the expression of mutant neural crest cells Birth Defects Original Article Series 15(8): 89-98
Mayer, F.J.; Crawford, E.D. 1994: The role of endocrine therapy in the management of local and distant recurrence of prostate cancer following radical prostatectomy or radiation therapy Urologic Clinics of North America 21(4): 707-715
Olivier, M. 2004: From SNPs to function: the effect of sequence variation on gene expression. Focus on "a survey of genetic and epigenetic variation affecting human gene expression" Physiological Genomics 16(2): 182-183
Marcus, D.M.; Canter, D.J.; Jani, A.B.; Dobbs, R.W.; Schuster, D.M.; Carthon, B.C.; Rossi, P.J. 2012: Salvage therapy for locally recurrent prostate cancer after radiation Canadian Journal of Urology 19(6): 6534-6541
Montie, J.E. 1994: Follow-up after radical prostatectomy or radiation therapy for prostate cancer Urologic Clinics of North America 21(4): 673-676
Akimoto, T.; Niibe, H. 2000: Recto-vesical morbidity in radiation therapy for prostate cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 58 Suppl: 284-287